Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Rando
about
Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataPost-operative radiation therapyPostoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.Adjuvant chemotherapy of non-small-cell lung cancer.Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results databaseEfficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancerNomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patientsAdvances in adjuvant systemic therapy for non-small-cell lung cancer.Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis.The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer.Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapyThe emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.Adjuvant therapy in non-small cell lung cancer: current and future directions.Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.Postoperative radiotherapy for elderly patients with stage III lung cancer.The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.Resectable left lower lobe non-small cell lung cancer with lymph node metastasis is related to unfavorable outcomes.Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancerAdjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancerPrognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.Optimal sequencing of adjuvant chemotherapy and radiation therapy in resected non-small cell lung cancer with pathological N2 diseaseChemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancerPostoperative radiation therapy for non-small cell lung cancer and thymic malignancies.Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach.Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer.Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer.The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy's efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patientsPost-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer.Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.Therapeutic management options for stage III non-small cell lung cancer.Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials.Controversies in the management of stage III non-small-cell lung cancer.Radiotherapy for single station N2 NSCLC.Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art.Proton Beam Therapy for Non-Small Cell Lung Cancer: Current Clinical Evidence and Future Directions.
P2860
Q24633254-DBF281ED-FBF7-4EE5-9F6D-00C06DC9E8FEQ26830376-F349CCA5-5E2F-4648-B839-38A6EEEF9155Q30868582-F8E9F1A0-B763-4627-BDAE-370307547781Q30890572-AC7D145A-B6D9-4785-9952-6D66C98AAB4BQ33698361-4608AE3B-BFD2-4703-A707-5F2B211D7DCBQ33698439-EA070F04-3990-4C17-9461-2A428577E122Q33796191-D234164F-C02C-4D9A-BE5E-B90E51680842Q33798819-9D1668F3-15CF-48DA-ADF6-4132457E7F69Q33913885-50422091-0746-45BE-8794-8312AF7B910CQ34031225-8E3B164E-07D7-4330-80B8-E173E3F04431Q34062649-3A5B4166-B4E0-410E-ACB1-5772DE1D4A33Q34325455-03C4F43D-E54B-48A6-8078-FE720F8B6AB7Q34610099-CA5A6996-7156-4A6E-B8F5-FC22221D790DQ35584147-E869EA28-950B-4B73-A602-CA233A416F84Q35584223-C7545D99-168C-481A-AA68-309D324B77E8Q35584905-92175BE6-F36B-4B4C-A284-62F6BF056608Q35663412-AA0E99A4-0977-4B79-9626-971E162E1FFEQ35771994-D580F2C5-D6A1-477C-A847-B17B90C32EE2Q35954065-338EC6FF-E2E7-4150-B9D2-595063DDC188Q35968871-B1139196-5717-4809-BD84-DEDD7D5556C4Q36308285-E83E73BA-AFEE-4939-8931-89BD29B04193Q36439723-F5AFD94B-E41E-4DCB-B835-344EB8C85070Q36617872-10AEA2C2-B3FD-46D6-A940-71AD28AB5DB4Q36631535-40E943CD-90DE-497F-81E5-E056DBA6612AQ36916445-58A2D87C-9D21-46E3-81E5-BA042352B4A1Q36948943-87F044E7-DC2C-4F14-B6EB-583A34B11846Q36989648-F4E8D738-FF5B-479E-8A8B-5F2652C906ACQ37016941-E2D5D640-EC80-4FFD-9B81-5895ED135A3DQ37121332-D4717BB4-4D42-4F65-8BA0-BBB3865AAA3BQ37121482-C244E5C5-EE95-436B-A6BF-E7C2DD24BD7BQ37343460-EA425F43-C8FD-459F-BB23-AB03839CB75CQ37344543-031AE7DD-7BC3-482D-80F8-36CB81697628Q37456466-6DE56EAB-706D-43A8-A547-9E063AFF137CQ37581168-57CC3789-0194-412D-9599-6838F4A8E24EQ37642455-542FF437-FC6F-4E82-A3B3-C6ACB55A19EFQ38118178-EFA58DFF-C41D-4ED9-A210-9536643095B7Q38176433-41D1049C-444A-4EA4-A77D-74B40BEC0916Q38390158-A0A57E54-C8B9-44DA-A97A-9DF2CB1E4AAAQ38419828-4D669C2C-5BDB-45A6-A001-6828D92C1AFDQ38543109-6B007E16-39F4-4B28-8D69-FC1892585B8B
P2860
Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Rando
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Impact of postoperative radiat ...... list Association (ANITA) Rando
@en
Impact of postoperative radiat ...... list Association (ANITA) Rando
@nl
type
label
Impact of postoperative radiat ...... list Association (ANITA) Rando
@en
Impact of postoperative radiat ...... list Association (ANITA) Rando
@nl
prefLabel
Impact of postoperative radiat ...... list Association (ANITA) Rando
@en
Impact of postoperative radiat ...... list Association (ANITA) Rando
@nl
P2093
P921
P1476
Impact of postoperative radiat ...... list Association (ANITA) Rando
@en
P2093
Adjuvant Navelbine International Trialist Association
Marc-Andre Mahe
Marcello Riggi
Mario De Lena
Patrick Hurteloup
P304
P356
10.1016/J.IJROBP.2008.01.044
P407
P577
2008-04-24T00:00:00Z